Medical prevention of breast cancer

Breast Care
Johannes StubertBernd Gerber

Abstract

Breast cancer is the most common cancer of women in Western Europe and North America. Effective strategies of medical prevention could reduce the burden of breast cancer mortality. The best evidence for a risk reduction exists for hormonal agents such as tamoxifen and raloxifene (22-72%) or aromatase inhibitors (50-65%). However, the severity of side effects and the lack of evidence for an improved survival compromise the risk/benefit balance. In this review the results of chemoprevention studies, including new treatment approaches, are summarized with critical discussion of their use in clinical practice.

Citations

Sep 8, 2015·Vaccines·Pier-Luigi LolliniElena Quaglino
Jun 23, 2015·Journal of Cellular Physiology·Jon M CarthyAristidis Moustakas
Mar 28, 2017·Breast Cancer Research : BCR·Tasleem J PadamseeElectra D Paskett
Jun 3, 2016·Physiology·Jennifer Blakemore, Fredrick Naftolin
Apr 30, 2019·The Cochrane Database of Systematic Reviews·Simone MocellinSandro Pasquali

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

© 2022 Meta ULC. All rights reserved